Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Analytica Chimica Acta
|
March 1, 1974
Fluorimetric assay of ergotamine
W D Hooper, J M Sutherland, M J Eadie, et al.
Journal of the Neurological Sciences
|
October 1, 1975
Quantitative oxidative enzyme histochemistry of the spinal cord. Part 2. Relation of cell size and enzyme activity to vulnerability to ischaemia
J E Penny, J R Kukums, J H Tyrer, et al.
Clinical Pharmacokinetics
|
January 1, 1979
Factors influencing plasma concentrations of ethosuximide
G A Smith, L McKauge, D Dubetz, et al.
British Journal of Clinical Pharmacology
|
July 1, 1979
Effects of subjects' sex, and intake of tobacco, alcohol and oral contraceptives on plasma phenytoin levels
E A De Leacy, C D McLeay, M J Eadie, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 1, 1984
Cortisol production during high dose dexamethasone therapy in neurological and neurosurgical patients
T Brophy, J B Chalk, K Ridgeway, et al.
Proceedings of the Australian Association of Neurologists
|
January 1, 1975
The bioavailability of carbamazepine
L M Cotter, G Smith, W D Hooper, et al.
Australian and New Zealand Journal of Medicine
|
August 1, 1973
The effect of certain drugs on the plasma protein binding of phenytoin
W D Hooper, J M Sutherland, F Bochner, et al.
European Journal of Clinical Pharmacology
|
January 1, 1983
Aspirin pharmacokinetics in migraine. The effect of metoclopramide
L M Ross-Lee, M J Eadie, V Heazlewood, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1973
The renal handling of diphenylhydantoin and 5-(p-hydroxyphenyl)-5-phenylhydantoin
F Bochner, W D Hooper, J M Sutherland, et al.
European Journal of Clinical Pharmacology
|
January 1, 1984
Pharmacokinetics of midazolam in the aged
M T Smith, V Heazlewood, M J Eadie, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Analytica Chimica Acta
|
March 1, 1974
Fluorimetric assay of ergotamine
W D Hooper, J M Sutherland, M J Eadie, et al.
Journal of the Neurological Sciences
|
October 1, 1975
Quantitative oxidative enzyme histochemistry of the spinal cord. Part 2. Relation of cell size and enzyme activity to vulnerability to ischaemia
J E Penny, J R Kukums, J H Tyrer, et al.
Clinical Pharmacokinetics
|
January 1, 1979
Factors influencing plasma concentrations of ethosuximide
G A Smith, L McKauge, D Dubetz, et al.
British Journal of Clinical Pharmacology
|
July 1, 1979
Effects of subjects' sex, and intake of tobacco, alcohol and oral contraceptives on plasma phenytoin levels
E A De Leacy, C D McLeay, M J Eadie, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 1, 1984
Cortisol production during high dose dexamethasone therapy in neurological and neurosurgical patients
T Brophy, J B Chalk, K Ridgeway, et al.
Proceedings of the Australian Association of Neurologists
|
January 1, 1975
The bioavailability of carbamazepine
L M Cotter, G Smith, W D Hooper, et al.
Australian and New Zealand Journal of Medicine
|
August 1, 1973
The effect of certain drugs on the plasma protein binding of phenytoin
W D Hooper, J M Sutherland, F Bochner, et al.
European Journal of Clinical Pharmacology
|
January 1, 1983
Aspirin pharmacokinetics in migraine. The effect of metoclopramide
L M Ross-Lee, M J Eadie, V Heazlewood, et al.
Clinical Pharmacology and Therapeutics
|
September 1, 1973
The renal handling of diphenylhydantoin and 5-(p-hydroxyphenyl)-5-phenylhydantoin
F Bochner, W D Hooper, J M Sutherland, et al.
European Journal of Clinical Pharmacology
|
January 1, 1984
Pharmacokinetics of midazolam in the aged
M T Smith, V Heazlewood, M J Eadie, et al.
Page
of 7